PB2113: FRONTMIND: A PHASE III, RANDOMIZED, DOUBLE-BLIND STUDY OF TAFASITAMAB + LENALIDOMIDE + R-CHOP VS R-CHOP ALONE FOR NEWLY DIAGNOSED HIGH-INTERMEDIATE AND HIGH-RISK DIFFUSE LA...

por Vitolo, U., Nowakowski, G. S., Burke, J. M., Fox, C. P., Trneny, M., Chiappella, A., Waldron-Lynch, M., Hadar, N., Pachori, A., Lenz, G.
Publicado 2022

PB2110: PHARMACOKINETICS AND PHARMACODYNAMICS IN FIRST-MIND: A PHASE IB, OPEN-LABEL, RANDOMIZED STUDY OF TAFASITAMAB ± LENALIDOMIDE + R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUS...

por Belada, D., Kopeckova, K., Bergua Burgues, J. M., Stevens, D., Nowakowski, G. S., Waldron-Lynch, M., Hadar, N., Weirather, J., Lässig, C., Blair, D., Dreyling, M.
Publicado 2022